Belgium’s MRM Health has concluded a Series B funding round, raising €55m ($64m) to progress its pipeline of microbiome-based biotherapeutic products. The financing round was spearheaded by French ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback